Immune Checkpoint Inhibitor-related Colitis
📧 Sign up to get email alerts when something new happens for Immune Checkpoint Inhibitor-related Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Early Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial [Phase 2]
A Phase 2 trial evaluating Vedolizumab as first-line therapy for immune checkpoint inhibitor–related colitis is currently recruiting.